ArticleScientific reports2026
Stage-dependent analysis of IL-6, TGF-β, osteocalcin, and sRANKL in the synovial fluid of dogs with osteoarthritis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Therapeutic Dilemma to Precision Modulation: Harnessing Biomaterials to Target the Dual Face of TGF-β in Osteoarthritis.Journal of inflammation research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis (OA) is traditionally considered a degenerative joint disease. However, morphological similarities between OA progression and fracture healing suggest that OA may be a dysregulated bone repair process. This study investigated the morphological and biochemical parallels between OA and bone healing in dogs following cranial cruciate ligament rupture. To differentiate between biochemical profiles at different stages of the disease, a structured OA scoring system was developed based on radiographic and additional intraoperative findings. Synovial fluid samples from the OA cohort were analysed for IL-6, TGF-β, osteocalcin and sRANKL. IL-6 concentrations decreased significantly with advancing OA severity (p = 0.0068), suggesting a shift from inflammatory to reparative mechanisms. TGF-β, osteocalcin and sRANKL demonstrated stage-dependent trends consistent with osteogenic and remodelling activity. However, these associations did not reach statistical significance. The combined morphological and biomarker findings suggest that OA progression exhibits features similar to the phases of bone healing, which are characterised by dynamic interactions between inflammation, resorption, and bone formation. Nevertheless, the predominantly non-significant biomarker correlations highlight the need for larger sample sizes and longitudinal studies to confirm these observations and further clarify causal mechanisms. These results support the concept that OA may represent a chronic but dysregulated adaptive repair response to joint damage, rather than a purely degenerative process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.